ΕΟΦ
Recalls rapid test for the coronavirus
- 30 Apr 2023
- timeliness
The EOF announced the withdrawal from the market of the rapid test (with a saliva sample) for the diagnosis of COVID-19.
The reason for the withdrawal from the EOF is that the rapid test in question "does not meet the provisions of the legislation on In Vitro Diagnostic Medical Devices".
The rapid test recalled by the EOF is the SARS-CoV-2/Flu A/Flu B Saliva Antigen Rapid Test (Colloidal Gold Method) of the manufacturer GUANGZHOU YUNRUI MEDICAL TECHNOLOGY CO., LTD China, with Ex. Representative for the E.U. the company SUNGO EUROPE B.V., the Netherlands, available on the market since HEALTH PROTECT LIMITED LIABILITY COMPANY AND 4CAST LOGISTICS.
